---
annotations:
- id: PW:0000263
  parent: regulatory pathway
  type: Pathway Ontology
  value: altered regulatory pathway
- id: DOID:162
  parent: disease of cellular proliferation
  type: Disease Ontology
  value: cancer
authors:
- Ruudweijer
- MaintBot
- Khanspers
- AlexanderPico
- Fehrhart
- Eweitz
citedin:
- link: PMC9377275
  title: 'Identifying Drug-Induced Liver Injury Associated With Inflammation-Drug
    and Drug-Drug Interactions in Pharmacologic Treatments for COVID-19 by Bioinformatics
    and System Biology Analyses: The Role of Pregnane X Receptor (2022)'
- link: PMC8431385
  title: Investigating the Molecular Processes behind the Cell-Specific Toxicity Response
    to Titanium Dioxide Nanobelts (2021)
- link: PMC7756074
  title: A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing
    Cytokine Storm and Virus in SARS-CoV-2 Infection (2020)
- link: PMC7665362
  title: Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic
    pulmonary fibrosis (IPF) patients (2020)
- link: PMC6321131
  title: Wound-Healing Markers Revealed by Proximity Extension Assay in Tears of Patients
    following Glaucoma Surgery (2018)
- link: PMC9664052
  title: Systems biology approach reveals a common molecular basis for COVID-19 and
    non-alcoholic fatty liver disease (NAFLD) (2022)
- link: 10.1097/MD.0000000000033917
  title: Exploring the pharmacological mechanism of Duhuo Jisheng Decoction in treating
    intervertebral disc degeneration based on network pharmacology (2023)
- link: 10.1371/journal.pone.0281981
  title: Identification of host genomic biomarkers from multiple transcriptomics datasets
    for diagnosis and therapies of SARS-CoV-2 infections (2023)
- link: 10.3389/fimmu.2021.769011
  title: 'A Practical Strategy for Exploring the Pharmacological Mechanism of Luteolin
    Against COVID-19/Asthma Comorbidity: Findings of System Pharmacology and Bioinformatics
    Analysis (2024)'
communities:
- CPTAC
description: Photodynamic therapy may induce a pro-inflammatory and angiogenic response
  mediated by NF-κB.   Proteins on this pathway have targeted assays available via
  the [CPTAC Assay Portal](https://assays.cancer.gov/available_assays?wp_id=WP3617).
last-edited: 2025-03-03
ndex: 3de06330-8b67-11eb-9e72-0ac135e8bacf
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP3617
- /instance/WP3617
- /instance/WP3617_r137121
revision: r137121
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP3617.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: Photodynamic therapy may induce a pro-inflammatory and angiogenic response
    mediated by NF-κB.   Proteins on this pathway have targeted assays available via
    the [CPTAC Assay Portal](https://assays.cancer.gov/available_assays?wp_id=WP3617).
  keywords:
  - BCL2A1
  - BCL2L2
  - BIRC2
  - BIRC3
  - BIRC5
  - CCND1
  - CD40LG
  - CFLAR
  - CHUK
  - CSF2
  - CXCL2
  - EGLN2
  - ICAM1
  - IKBKB
  - IL1A
  - IL1B
  - IL2
  - IL6
  - IL8
  - MMP1
  - MMP2
  - MMP3
  - MMP9
  - NFKB1
  - NFKB2
  - PTGS2
  - REL
  - RELA
  - RELB
  - ROS
  - SELE
  - TNF
  - TNFRSF1A
  - TRAF6
  - VCAM1
  - VEGFA
  license: CC0
  name: Photodynamic therapy-induced NF-kB survival signaling
seo: CreativeWork
title: Photodynamic therapy-induced NF-kB survival signaling
wpid: WP3617
---